EDIT- Editas Medicine, Inc.

Insider activity in EDIT over the last quarter tilts toward selling: insiders offloaded a net 11,892 shares worth roughly $34K.

EDIT sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
VP	Ory Daniel Scott	950.0K	-	-
CEO	O'Neill Gilmore Neil	243.2K	$738.6K	-
Dir	Ellinor Patrick Thomas II	103.4K	-	-
VP	Burkly Linda	61.7K	$187.3K	-
Dir	Scadden David	51.7K	-	-

Buys and sells only

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 3, 2026	O'Neill Gilmore Neil69	CEO	Sell	5,124	$3.04	$15,562.61	-2.1%	-	-
Sep 3, 2026	Parison Amy	SVP, Chief Financial Officer	Sell	453	$3.04	$1,375.85	-3.2%	-	-
Sep 3, 2026	Burkly Linda48	EVP, Chief Scientific Officer	Sell	709	$3.04	$2,153.37	-1.1%	-	-
Aug 3, 2026	Parison Amy	SVP, Chief Financial Officer	Sell	678	$2.58	$1,749.24	-4.5%	-	-
Jul 28, 2026	Burkly Linda48	EVP, Chief Scientific Officer	Sell	4,928	$2.67	$13,157.76	-7.3%	-8.4%	-
Jun 3, 2026	Parison Amy	SVP, Chief Financial Officer	Sell	464	$2.70	$1,253.26	-3.0%	+10.4%	-
Jun 3, 2026	O'Neill Gilmore Neil69	CEO	Sell	15,380	$2.70	$41,542.92	-5.8%	+10.4%	-
Jun 3, 2026	Burkly Linda48	EVP, Chief Scientific Officer	Sell	731	$2.70	$1,974.50	-1.1%	+10.4%	-
Mar 3, 2026	O'Neill Gilmore Neil69	CEO	Sell	5,394	$2.02	$10,894.26	-2.0%	+63.7%	-
Mar 3, 2026	Parison Amy	SVP, Chief Financial Officer	Sell	474	$2.02	$957.48	-3.0%	+63.7%	-